Transcranial magnetic stimulation for depression.
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D054598:Blue Cross Blue Shield Insurance Plans; D003863:Depression / Q000188:drug therapy / Q000628:therapy*; D018795:Device Approval; D004351:Drug Resistance; D006801:Humans; D015201:Meta-Analysis as Topic; D017063:Outcome Assessment, Health Care; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D013673:Technology Assessment, Biomedical; D050781:Transcranial Magnetic Stimulation / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D000928:Antidepressive Agents